|
WO2011088075A2
|
|
Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
|
|
WO2010093804A1
|
|
Ace2 inhibitors for reducing gastrointestinal adverse effects of cytotoxic agents
|
|
WO2010014771A1
|
|
Romazarit for treating metabolic diseases
|
|
EP2323662A1
|
|
Treating inflammation and related conditions with irindalone
|
|
WO2010006103A1
|
|
Method for enhancing cognition or inhibiting cognitive decline
|
|
US2009325237A1
|
|
Method of Analyzing a BRCA2 Gene in a Human Subject
|
|
US2010029734A1
|
|
Methods for breast cancer screening and treatment
|
|
WO2009114516A1
|
|
Therapy for disorders of the proximal digestive tract
|
|
US2009192220A1
|
|
Treatment for solid tumors
|
|
WO2009049022A1
|
|
Method for treatment of pancreatitis
|
|
US2010209914A1
|
|
Methods, systems, and kits for evaluating multiple sclerosis
|
|
US2009012052A1
|
|
Method for treating er+ breast cancer
|
|
AU2007319505A1
|
|
Breast cancer screening and treatment methods
|
|
US2008107650A1
|
|
Method for treating inflammatory diseases of the digestive tract
|
|
EP2059234A1
|
|
Method for reducing or alleviating inflammation in the digestive tract
|
|
AU2004202804A1
|
|
Melanocortin-4 Receptor Binding Compounds and Methods of use thereof
|
|
AU2003297629A1
|
|
Modulators of melanocortin receptor
|
|
US2004082779A1
|
|
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
EP1363890A2
|
|
Melanocortin-4 receptor binding compounds and methods of use thereof
|
